🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 2-European shares boosted by earnings, progress on coronavirus treatment

Published 2020/02/05, 19:46
© Reuters.  UPDATE 2-European shares boosted by earnings, progress on coronavirus treatment
SGEF
-
IFXGn
-
IMB
-
SWR
-
STOXX
-
SX8P
-
SXOP
-
SXQP
-

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

* STOXX 600 up for third straight session

* China, UK researchers make progress in coronavirus treatment

* Novo Nordisk , Valmet, Infineon rally after results

* GlaxoSmithKline, Imperial Brands at bottom of STOXX 600

* Airbus slips on halting output at China plant

(Updates to close)

By Susan Mathew

Feb 5 (Reuters) - A clutch of upbeat earnings and reports of progress in treatment for the fast-spreading coronavirus helped to push European shares towards record highs on Wednesday.

Drugmaker Novo Nordisk NOVOb.CO rose 4.6% and industrial company Valmet VALMT.HE and chipmaker Infineon IFXGn.DE both surged more than 10% after results, taking the pan-European stock benchmark STOXX 600 index up 1.2% in its third day of gains.

The index is now just 0.3% shy of record highs hit last month. The rally this week comes after a virus outbreak in China sent markets into a tailspin as investors gauged the potential economic damage from production and supply disruptions. Wednesday, reports from China and the UK that researchers are closing in on a vaccine to treat the virus, lifted sentiment as the death toll in China moved closer to 500. sectors such as autos .SXAP , technology .SX8P and basic materials .SXPP were among the strongest performers.

"It is driven by what we see around the coronavirus and more importantly, the reporting season so far has been pretty reasonable across a number of different sectors," said Will James, deputy head of European equities at Aberdeen Standard Investments.

Companies listed on the STOXX 600 are forecast to report 1.2% earnings growth in the fourth quarter, just a touch below the 1.3% growth rate expected last week, according to the latest data from I/B/E/S Refinitiv. This would follow three straight quarters of declining profits. showing an acceleration of euro zone business activity in January, added to the upbeat mood. tempering the positive expectations was a near 7% drop in cigarette maker Imperial Brands Plc IMB.L after it forecast a fall in its first-half profit, while GlaxoSmithKline GSK.L slipped after missing fourth-quarter earnings forecasts. Airbus AIR.PA fell after the company said it was prolonging a planned closure of its final assembly plant in Tianjin, China, as a result of the coronavirus emergency.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.